Preparation and in-vitro in-vivo evaluation of sustained release matrix diclofenac sodium tablets using PVP-K90 and natural gums

Pakistan Journal of Pharmaceutical Sciences

Volumn 24, Issue 4, 2011, Pages 435-443

  Iqbal, Zafar ^a   Khan, Raza ^a   Nasir, Fazli ^a   Khan, Jamshaid Ali ^a   Rashid, Abdur ^b   Khan, Abbas ^a   Khan, Abad ^a  

^a UNIVERSITY OF PESHAWAR   (Pakistan)

^b NATIONAL INSTITUTE OF HEALTH   (Pakistan)

Author keywords

Guar gum; Gum tragacanth; PVP K90; Sustained release; Xanthan gum

Indexed keywords

BICARBONATE; CITRATE SODIUM; DICLOFENAC; GUAR GUM; GUM TRAGACANTH; LACTOSE; POVIDONE; PVP K90; UNCLASSIFIED DRUG; XANTHAN;

ADULT; ARTICLE; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG GRANULE; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; NORMAL HUMAN; SINGLE DRUG DOSE; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION; TABLET FORMULATION;

ADULT; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DICLOFENAC; GALACTANS; HARDNESS; HUMANS; MALE; MANNANS; PLANT GUMS; POLYSACCHARIDES, BACTERIAL; POVIDONE; TABLETS; TRAGACANTH; YOUNG ADULT;

EID: 80053460050     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Aguzzi C, Bonferoni M, Fortich M, Rossi S, Ferrari F and Caramella C (2002). Influence of complex solubility on formulations based on lambda carrageenan and basic drugs. AAPS Pharm. SciTech., 3: 83-89.
2. Aulton M (1988). Pharmaceutical technology. Pharmaceutics: The Science of Dosage Form Design, pp. 600-616.
3. Baweja J and Misra A (1997). Modified guar gum as a tablet disintegrant. Pharmazie, 52: 856-859. (Pubitemid 27489311)
4. Berner-Strzelczyk A, Ko odziejska J and Zgoda M (2006). Application of guar gum biopolymer in the prescription of tablets with sodium ibuprofen-quality tests and pharmaceutical availability in vitro. Polim Med., 36: 3-11.
5. Castro I, Tirapegui J and Benedicto M (2003). Effects of diet supplementation with three soluble polysaccharides on serum lipid levels of hypercholesterolemic rats. Food Chem., 80: 323-330. (Pubitemid 36043898)
6. Chien YW (1992). Novel drug delivery systems. Drug and the pharmaceutical sciences, Informa Healthcare, 2nd ed., MARCEL DEKKER, INC., New York, pp. 139-196.
7. Cooper J and Gunn C (1986). Powder flow and compaction. Tutorial Pharmacy, CBS Publishers and Distributors., New Delhi, India, pp. 211-233.
8. Costa P (2001). An alternative method to the evaluation of similarity factor in dissolution testing. Int. J. Pharmaceut., 220: 77-83.
9. Díez-Peña E, Quijada-Garrido I, Barrales-Rienda J, Schnell I and Spiess H (2004). Advanced 1H Solid-State NMR Spectroscopy on Hydrogels, 1. Macromol. Chem. Phys., 205: 430-437.
10. Dhopeshwarkar V, O Keeffe J, Zatz J, Deete R and Horton M (1994). Development of An Oral Sustained-Release Antibiotic Matrix Tablet Using In-Vitro/In-Vivo Correlations. Drug Dev. Ind. Pharm., 20: 1851-1867.
11. Emami J (2006). In vitro-in vivo correlation: from theory to applications. J. Pharm. Pharmaceut. Sci., 31-52.
12. Gao P and Meury R (2000). Swelling of hydroxypropyl methylcellulose matrix tablets. Characterization of swelling using a novel optical imaging method. J. Pharm. Sci., 85: 725-731. (Pubitemid 26234677)
13. Gohel M and Amin A (1998). Formulation optimization of controlled release diclofenac sodium microspheres using factorial design. J. Control. Release., 51: 115-122. (Pubitemid 28252862)
14. Higuchi T (1963). Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. Mechanisms of sustained action medication. J Pharm., 52: 1145-1149.
15. Khullar P, Khar R and Agarwal S (1998). Evaluation of guar gum in the preparation of sustained-release matrix tablets. Drug Dev. Ind.Pharm., 24: 1095-1099. (Pubitemid 28460250)
16. Krishnaiah Y, Karthikeyan R, Gouri Sankar V and Satyanarayana V (2002). Three-layer guar gum matrix tablet formulations for oral controlled delivery of highly soluble trimetazidine dihydrochloride. J. Control. Release., 81: 45-56. (Pubitemid 34454848)
17. Kumar MNVR and Neeraj Kumar (2001) . Polymeric controlled drug-delivery systems: Perspective issues and opportunities. Drug. Dev. Ind. Pharm., 27: 1-30.
18. Lu M, Woodward L and Borodkin S (1991). Xanthan gum and alginate based controlled release theophylline formulations. Drug Dev. Ind. Pharm., 17: 1987-2004.
19. Misra A and Baweja J (1997). Modified guar gum as hydrophilic matrix for controlled release tablets. Indian drugs., 34: 216-223.
20. Mutalik S and Hiremath D (2000). Formulation and evaluation of chitosan matrix tablets of nifedipine. The Eastern Pharmacist., 2: 109-111.
21. Nishi K, Antony M, Mohanan P, Anilkumar T, Loiseau P and Jayakrishnan A (2007). Amphotericin B-Gum Arabic Conjugates: Synthesis, Toxicity, Bioavailability, and Activities Against Leishmania and Fungi. Pharmaceutl Res., 24: 971-980. (Pubitemid 46675399)
22. Nokhodchi A, Norouzi-Sani S, Siahi-Shadbad M, Lotfipoor F and Saeedi M (2002). The effect of various surfactants on the release rate of propranolol hydrochloride from hydroxypropylmethylcellulose (HPMC)-Eudragit matrices. Eur. J. Pharm. Biopharm., 54: 349-356. (Pubitemid 35341837)
23. Peppas N (1985). Analysis of Fickian and non-Fickian drug release from polymers. Pharmaceutica. Acta. Helvetiae., 60: 110.
24. Pharmacopoeia B (2004). Her Majesty's Stationery Office., London
25. Reza M, Quadir M and Haider S (2002). Development of theophylline sustained release dosage form based on kollidon SR. Pak J Pharm Sci., 15: 63-70.
26. Rowe R, Sheskey P and Weller P (2003). Guar gum. Hand Book of Pharmaceutical Excipients, 4th ed London: Pharmaceutical Press and American Pharmaceutical Association: pp. 271-273.
27. Sankar C, Rani M, Srivastava A and Mishra B (2001). Chitosan based pentazocine microspheres for intranasal systemic delivery: development and biopharmaceutical evaluation. Pharmazie., 56: 223-226. (Pubitemid 32209948)
28. Shah D, Shah Y and Pradhan R (1997). Development and evaluation of controlled-release diltiazem HCl microparticles using cross-linked poly (vinyl alcohol). Drug Dev. Ind. Pharm., 23: 567-574. (Pubitemid 27238955)
29. Sheu M, Chou H, Kao C and Liu C (1992). Dissolution of diclofenac sodium from matrix tablets. Int. J. Pharmaceut., 85: 57-63.
30. Su S, Chou C, Kung C and Huang J (2003). In vitro and in vivo comparison of two diclofenac sodium sustained release oral formulations. Int. J. Pharmaceut., 260: 39-46. (Pubitemid 36724859)
31. Sung CK, Nixon P, Skoug J, Ju T, Ping G and Topp E (1996). Effect of formulation variables on drug and polymer release from HPMC-based matrix tablets. Int. J. Pharmaceut., 142: 53-60. (Pubitemid 26343829)
32. Tahara K, Yamamoto K and Nishihata T (1996). Application of model-independent and model analysis for the investigation of effect of drug solubility on its release rate from hydroxypropyl methylcellulose sustained release tablets. Int. J. Pharmaceut.,133: 17-27. (Pubitemid 26160831)
33. Toti U and Aminabhavi T (2004). Modified guar gum matrix tablet for controlled release of diltiazem hydrochloride. J. Control. Release., 95: 567-577. (Pubitemid 38340506)
34. Varshosaz J, Tavakoli N and Eram S (2006). Use of natural gums and cellulose derivatives in production of sustained release metoprolol tablets. Drug Deliv., 13: 113-119. (Pubitemid 43162307)
35. Vazquez M, Perez-Marcos B, Gomez-Amoza J, Pacheco R, Souto C and Concheiro A (1992). Influence of technological variables on release of drugs from hydrophilic matrices. Drug. Dev. Ind. Pharm., 18: 1355-1375.
36. Vlachou M, Hani N, Efentakis M, Tarantili P and Andreopoulos A (2000). Polymers for use in controlled release systems: The effect of surfactants on their swelling properties. Journal of biomaterials applications., 15: 65.
37. Wassel G, Omar S and Ammar N (1989). Application of guar flour and prepared guaran in tablet manufacture. J. Drug. Res.,18: 1-8.
38. Williams J (2008). The Declaration of Helsinki and public health; Bulletin of the World Health Organization; 86: 650-652.